What Researchers Did
Researchers retrospectively analyzed data from 59 patients with sudden sensorineural hearing loss to determine if the timing of hyperbaric oxygen therapy affected treatment outcomes.
What They Found
All 59 patients showed statistically significant hearing improvement after hyperbaric oxygen therapy. Patients starting therapy within 14 days (Group A: 1-7 days, Group B: 8-14 days) experienced significantly greater hearing gains than those starting between 15 and 28 days (Group C), with no significant difference between Group A and Group B.
What This Means for Canadian Patients
Canadian patients experiencing sudden sensorineural hearing loss may benefit most from hyperbaric oxygen therapy if initiated within the first two weeks. Prompt medical evaluation and treatment are crucial to maximize potential hearing recovery.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
The study's retrospective design and small sample size of 59 patients limit the generalizability of its findings.